Zobrazeno 1 - 9
of 9
pro vyhledávání: '"59"'
Autor:
Hirokazu Nakamine, Masataka Okamoto, Sadao Aoki, Shigeki Motomura, Masami Hirano, Nozomi Niitsu
Publikováno v:
Hematological oncology. 26(3)
We studied the clinico-pathologic features and treatment outcome of patients with peripheral T-cell lymphoma (PTCL). This study included 215 patients with T/natural killer (NK)-cell lymphoma, including 59 with PTCL-unspecified (PTCL-U), 42 with angio
Autor:
Anna Kopińska, Iwona Hus, Wieslaw Wiktor-Jedrzejczak, Andrzej Szczepaniak, Piotr Smolewski, Dariusz Wołowiec, Wanda Knopinska-Posluszny, Justyna Rybka, Olga Grzybowska-Izydorczyk, Kazimierz Hałaburda, Anna Waszczuk-Gajda, Sebastian Giebel, Krzysztof Jamroziak, Jadwiga Hołojda, Joanna Drozd-Sokołowska, Jacek Kwiatkowski, Magdalena Witkowska, Tomasz Żółtak, Edyta Subocz, Jan Maciej Zaucha, Maciej Kaźmierczak
Publikováno v:
Hematological Oncology. 37:383-391
Richter transformation (RT) of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) to Hodgkin lymphoma (HL) is a rare and unexpected event in the course of the disease and data on this phenomenon is still limited. To better understand t
Autor:
Tamotsu Takeuchi, Senji Kasahara, Takuro Matsumoto, Michio Sawada, Soranobu Ninomiya, Yusuke Kito, Nobuhiko Nakamura, Takeshi Hara, Tsuyoshi Takami, Toshiki Yamada, Nobuhiro Kanemura, Junichi Kitagawa, Yuhei Shibata, Hiroshi Nakamura, Hisataka Moriwaki, Naoe Goto, Tatsuhiko Miyazaki, Hisashi Tsurumi
Publikováno v:
Hematological oncology. 35(3)
We have reported the efficacy of the salvage chemotherapy P-IMVP16/CBDCA for patients with diffuse large B cell lymphoma (DLBCL) who had previously received CHOP before the availability of rituximab (R). Here, we confirmed the efficacy of R combined
Publikováno v:
Hematological Oncology. 5:223-230
Twenty five patients with stage I and II diffuse aggressive non-Hodgkin's lymphoma of the Waldeyer's ring were reviewed. There were 19 patients with diffuse histiocytic, 4 diffuse lymphocytic poorly differentiated and 2 diffuse mixed lymphoma. Their
Autor:
R. Pfab, J. Birkmann, W. Zeller, H. H. Gossmann, Hubert Köppler, Karl-Heinz Pflüger, C. Gropp, H. Kuhn, E. U. Steinhauer, Klaus Havemann, E. Lötzke, S. Oehl, Harald Stein, I. Eschenbach, Karl Lennert, P. Drings
Publikováno v:
Hematological Oncology. 9:217-223
In a multicentre phase III trial 146 previously untreated patients with high grade non-Hodgkin's lymphomas stage II–IV were randomized to receive either four cycles of CHOEP (cyclophosphamide 750 mg/m2 iv d 1, doxorubicin 50 mg/m2 iv d 1, vincristi
Autor:
Corine Plancher, Bernard Asselain, Livia Lumbroso-Le Rouic, Christine Levy, Anne Vincent-Salomon, Didier Decaudin, Alain Fourquet, Driss Chaoui, Philippe Arnaud, Laurence Desjardins, Jérôme Meunier, Patricia Validire, R. Dendale
Publikováno v:
Hematological oncology. 22(4)
The aims of this study were to define the initial characteristics, natural history, and prognostic factors of patients with ophthalmologic and intraocular malignant lymphoma. All patients treated at the Institut Curie for lymphoma with ophthalmologic
Publikováno v:
Hematological oncology. 9(2)
From June 1983 to February 1986, 48 patients with intermediate or high-grade non-Hodgkin's lymphomas (NHL) received a CHOP based combination with the addition of etoposide on days 1 and 2, bleomycin days 1 and 10 and methotrexate 1.5 g/m2 on day 10 (
Publikováno v:
Hematological oncology. 7(3)
A retrospective morphologic survey (1973–1983) of 146 cases of malignant lymphoma among the Hawaii-Japanese (migrant Japanese and their offspring) was conducted to determine whether differences in the incidence and cytologic types of malignant lymp
Autor:
Musleh Tarawneh
Publikováno v:
Hematological oncology. 4(1)
Our hospital admitted 231 patients with non-Hodgkin's lymphomas between June 1976 and November 1984. Review of these cases revealed the following profile: ages ranged from 1 to 70 years (median: 30 years), 156 males, predominantly children and adoles